Department of Social Sciences and Humanities, Poznan University of Medical Sciences, Poznań, Poland.
Department of Organization and Management in Health Care, Poznan University of Medical Sciences, Poznań, Poland.
Oncologist. 2024 Jul 5;29(7):e887-e898. doi: 10.1093/oncolo/oyae078.
Although biobanks have become fundamental to many research centers and contribute to medical development, they generate many ethical and legal issues that may discourage patients from donating.
To understand patients' perception of ethical and legal issues related to biobanks we conducted a survey among 548 Polish patients with cancer.
While 93.1% of patients with cancer declared themselves willing to donate biospecimens left over after a medical procedure to a biobank, most opted for one-time consent or study-specific consent, blanket consent being less frequently preferred. Many patients believed that future use of previously collected tissues require second contact. Most patients preferred pseudonymization over anonymization of the data, and supported donors' right to withdraw informed consent at any given moment. Finally, while personal health information was the most expected form of compensation for donation, most patients suggested that all parties, including the biobank concerned, the sponsors of the research, and the donors, should own the rights to cancer tissues donated and profit from the biobank research. Patients' opinions on the ethical and legal issues related to biobank research were associated with age, sex, religiosity, education level, and place of residence.
Since biobanks generate ethical and legal issues related to informed consent, data protection and storage, as well as the sharing of biosamples, tissue ownership, and profit sharing, that may discourage patients from donation, when asking a patient for a donation, healthcare professionals should communicate in a donor-centered manner and address patients' ethical and moral concerns related to donation and offer resources to help manage these concerns.
生物银行已成为许多研究中心的基础,为医学发展做出了贡献,但也产生了许多可能阻碍患者捐赠的伦理和法律问题。
为了了解患者对与生物银行相关的伦理和法律问题的看法,我们对 548 名波兰癌症患者进行了一项调查。
虽然 93.1%的癌症患者表示愿意将医疗程序后留下的生物样本捐赠给生物银行,但大多数人选择一次性同意或特定研究同意,而不是普遍同意。许多患者认为,未来对以前收集的组织的使用需要再次联系。大多数患者更喜欢对数据进行化名处理而不是匿名化,并且支持捐赠者随时撤回知情同意的权利。最后,虽然个人健康信息是最期望的捐赠补偿形式,但大多数患者建议,包括生物银行、研究赞助商和捐赠者在内的所有各方都应拥有捐赠的癌症组织的所有权,并从生物银行研究中获利。患者对与生物银行研究相关的伦理和法律问题的看法与年龄、性别、宗教信仰、教育程度和居住地有关。
由于生物银行产生了与知情同意、数据保护和存储以及生物样本共享、组织所有权和利润分享相关的伦理和法律问题,这可能会阻碍患者的捐赠,因此,当向患者提出捐赠请求时,医疗保健专业人员应该以以捐赠者为中心的方式进行沟通,并解决患者与捐赠相关的伦理和道德问题,并提供资源来帮助管理这些问题。